Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Medication Treatments

News
Video DOT Improves Methadone Adherence Rates in Study
10/21/2022
Remote observation of methadone doses using asynchronous video-based directly observed therapy could allow OUD treatment programs to improve patients’ medication adherence rates.
Remote observation of methadone doses using asynchronous video-based directly observed therapy could allow OUD treatment programs to improve patients’ medication adherence rates.
Remote observation of methadone...
10/21/2022
Addiction Professional
News
Novel Intervention Enables Transition from Fentanyl to Buprenorphine in 1 Hour
10/07/2022
The process allows flexible timing as to last fentanyl use, provides greater autonomy in starting buprenorphine-naloxone treatment, and aligns with a patient’s readiness to start treatment immediately at home or in a clinical setting.
The process allows flexible timing as to last fentanyl use, provides greater autonomy in starting buprenorphine-naloxone treatment, and aligns with a patient’s readiness to start treatment immediately at home or in a clinical setting.
The process allows flexible...
10/07/2022
Addiction Professional
News
Psilocybin Improves Recovery Rate Among AUD Patients
08/31/2022
When combined with psychotherapy, 2 doses of psilocybin reduced drinking by an average of 83% among heavy drinkers, according to a new study led by researchers at NYU Grossman School of Medicine.
When combined with psychotherapy, 2 doses of psilocybin reduced drinking by an average of 83% among heavy drinkers, according to a new study led by researchers at NYU Grossman School of Medicine.
When combined with...
08/31/2022
Psych Congress Network
News
Out-of-Pocket Cost of Naloxone Soars for Uninsured Individuals
08/26/2022
While the cost of naloxone has declined for individuals with health insurance, the cost of the opioid overdose reversal medication for those without insurance increased by more than 500% from 2014 to 2018, according to new data from RAND...
While the cost of naloxone has declined for individuals with health insurance, the cost of the opioid overdose reversal medication for those without insurance increased by more than 500% from 2014 to 2018, according to new data from RAND...
While the cost of naloxone has...
08/26/2022
Addiction Professional
News
Nicotine Replacement Therapy May Also Reduce Alcohol Consumption
08/11/2022
Patches, gums, and nasal sprays prescribed for smoking cessation were found to be as effective in reducing alcohol consumption as prescribed varenicline and cytisine, according to a new study published in the journal JAMA Network Open.
Patches, gums, and nasal sprays prescribed for smoking cessation were found to be as effective in reducing alcohol consumption as prescribed varenicline and cytisine, according to a new study published in the journal JAMA Network Open.
Patches, gums, and nasal sprays...
08/11/2022
Psych Congress Network
News
Telehealth Improves MAT Engagement Among Vets with OUD
08/01/2022
Widespread adoption of telehealth during the COVID-19 pandemic has kept more veterans with opioid addiction engaged in medication-assisted treatment, according to a new study by the University of Michigan and VA Ann Arbor Healthcare System.
Widespread adoption of telehealth during the COVID-19 pandemic has kept more veterans with opioid addiction engaged in medication-assisted treatment, according to a new study by the University of Michigan and VA Ann Arbor Healthcare System.
Widespread adoption of...
08/01/2022
Addiction Professional
News
Medication to Treat Alcohol Use Disorder Shows Promise in Phase 3 Trial
07/28/2022
Adial Pharmaceuticals announced that in its ONWARD Phase 3 clinical study, its AD04 medication achieved a statistically significant mean reduction in heavy drinking days among a prespecified group of “heavy drinkers” compared to a placebo.
Adial Pharmaceuticals announced that in its ONWARD Phase 3 clinical study, its AD04 medication achieved a statistically significant mean reduction in heavy drinking days among a prespecified group of “heavy drinkers” compared to a placebo.
Adial Pharmaceuticals announced...
07/28/2022
Psych Congress Network
News
CODAC Launches Mobile Unit to Facilitate Medication-Assisted Treatment
07/19/2022
CODAC Behavioral Healthcare, a not-for-profit provider of outpatient opioid treatment in Rhode Island, announced on Monday that it has launched a mobile medical unit to dispense methadone, buprenorphine, and naltrexone for opioid use disorder...
CODAC Behavioral Healthcare, a not-for-profit provider of outpatient opioid treatment in Rhode Island, announced on Monday that it has launched a mobile medical unit to dispense methadone, buprenorphine, and naltrexone for opioid use disorder...
CODAC Behavioral Healthcare, a...
07/19/2022
Addiction Professional
News
Young Adults Filled Fewer Buprenorphine Prescriptions After Pandemic Started
07/12/2022
Buprenorphine prescriptions for young adults paid for by commercial insurance or cash, but not Medicaid, significantly decreased in the early months of the COVID-19 pandemic, according to a recent study.
Buprenorphine prescriptions for young adults paid for by commercial insurance or cash, but not Medicaid, significantly decreased in the early months of the COVID-19 pandemic, according to a recent study.
Buprenorphine prescriptions for...
07/12/2022
Addiction Professional
News
Just 1 in 5 Patients With Alcohol-Related Diagnosis Prescribed Medication to Treat AUD
07/07/2022
The findings indicate underprescribing of such medications, despite their demonstrated effectiveness in reducing heavy drinking and/or relapse.
The findings indicate underprescribing of such medications, despite their demonstrated effectiveness in reducing heavy drinking and/or relapse.
The findings indicate...
07/07/2022
Psych Congress Network

Advertisement

Advertisement

Browse Our Other Brands

Psych NP Institute

 

Psych Congress Network

 

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement